Imperva (NASDAQ:IMPV) Rating Maintained
Imperva (NASDAQ:IMPV) had its stock rating noted as Outperform by analysts at Imperial Capital. Imperial Capital currently has a $55.0 price target on the $1.39B market cap company or 19.83 % upside potential. This was disclosed in a report on Monday morning.
NASDAQ:IMPV is now trading -5.50% lower at $41.20 as of 6:04 PM New York time. Imperva’s stock is 0% over the last 200 days. It has underperformed the S&P 500 Index, which has risen 6.00% over the same time.
Out of 19 brokers covering Imperva, 19 rate it a Buy, 3 indicate a Hold while 0 suggest a Sell. The highest target is $77 and the lowest is $34 according to Thomson/First Call. The 12-month mean target is $55.74, which means upside potential of 35.29% over the current price.
Litespeed Management L.L.C. had the most significant stake with ownership of 943,915 shares as of q2 2015 for 20.25% of the equity exposure. Cooper Creek Partners Management Llc is another bullish investment manager who is owning 169,610 shares of Imperva or 5.41% of their equity exposure. In addition, 13D Management Llc have 4.98% of their equity exposure invested in the company for 222,419 shares. The New York-based fund Clearline Capital Lp disclosed it had acquired a stake worth about 2.09% of the investment manager’s stock portfolio in Imperva. The New York-based fund Hilltop Park Associates Llc is also positive about the stock, possessing 124,633 shares or 1.99% of their equity exposure.
Imperva (NASDAQ:IMPV) Profile
Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Imperva (NASDAQ:IMPV) traded down -5.50% on 12 February, hitting $41.2. A total of 359,801 shares of the company’s stock traded hands. This is up from average of 354,001 shares. Imperva has a 52 week low of $34.40 and a 52 week high of $52.4. The company has a market cap of $1.39 billion and a P/E ratio of 0.
Get the latest Imperva (NASDAQ:IMPV) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.